| |
| |
|
| Insider
Information: |
King Rachel K. |
| Relationship: |
Director |
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
525,244 |
|
|
Indirect Shares
|
146,101 |
|
|
| Direct
Value |
$889,747 |
|
|
|
Indirect Value
|
$248,301 |
|
|
| Total
Shares |
671,345 |
|
|
| Total
Value |
$1,138,047 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Glycomimetics Inc |
GLYC |
|
2024-03-29 |
515,194 |
2024-03-29 |
143,901 |
Premium* |
|
|
Novavax Inc |
NVAX |
Director |
2023-06-10 |
10,050 |
2023-06-10 |
2,200 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GLYC |
Glycomimetics Inc |
|
– • – |
2024-03-29 |
4 |
A |
$3.00 |
$10,002 |
D/D |
3,334 |
515,194 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
Director |
– • – |
2023-12-29 |
4 |
A |
$2.36 |
$10,002 |
D/D |
4,238 |
511,860 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
Director |
– • – |
2023-09-30 |
4 |
A |
$1.50 |
$10,001 |
D/D |
6,667 |
507,622 |
0 |
- |
|
| NVAX |
Novavax Inc |
Director |
– • – |
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,100 |
10,050 |
0 |
- |
|
| NVAX |
Novavax Inc |
Director |
– • – |
2022-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
700 |
6,950 |
0 |
- |
|
| NVAX |
Novavax Inc |
Director |
– • – |
2021-06-25 |
4/A |
OE |
$0.00 |
$0 |
D/D |
3,450 |
6,250 |
0 |
- |
|
| NVAX |
Novavax Inc |
Director |
– • – |
2021-06-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,900 |
9,700 |
0 |
- |
|
| NVAX |
Novavax Inc |
Director |
– • – |
2021-05-19 |
4 |
B |
$139.64 |
$97,748 |
D/D |
700 |
2,800 |
2.39 |
- |
|
| GLYC |
Glycomimetics Inc |
President, CEO |
• • – |
2021-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
96,250 |
452,314 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
President, CEO |
• • – |
2020-12-28 |
4 |
AS |
$3.91 |
$329,128 |
D/D |
(84,176) |
356,064 |
0 |
% |
|
| GLYC |
Glycomimetics Inc |
President, CEO |
• • – |
2020-12-28 |
4 |
OE |
$1.12 |
$146,520 |
D/D |
130,821 |
440,240 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
President, CEO |
• • – |
2019-08-06 |
4 |
OE |
$1.12 |
$186,770 |
D/D |
166,759 |
307,144 |
0 |
- |
|
| NVAX |
Novavax Inc |
Director |
– • – |
2019-03-27 |
4 |
B |
$0.53 |
$23,311 |
I/I |
44,000 |
22,000 |
2.1 |
- |
|
| NVAX |
Novavax Inc |
Director |
– • – |
2019-03-27 |
4 |
B |
$0.53 |
$22,252 |
D/D |
42,000 |
42,000 |
2.39 |
- |
|
| GLYC |
Glycomimetics Inc |
President, CEO |
• • – |
2015-02-24 |
4 |
OE |
$1.12 |
$56,000 |
D/D |
50,000 |
167,206 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
President, CEO |
• • – |
2014-06-18 |
4 |
OE |
$1.12 |
$112,000 |
D/D |
100,000 |
108,706 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
President, CEOOfficer |
• • – |
2014-01-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
159,096 |
|
- |
|
| GLYC |
Glycomimetics Inc |
President, CEOOfficer |
• • – |
2014-01-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,706 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
